Breakthrough trial aims to save lives from deadly Alcohol-Related liver disease
NCT ID NCT06956482
Summary
This study is testing whether extending standard steroid treatment or adding an antioxidant drug called N-acetylcysteine can improve outcomes for people with severe alcoholic hepatitis. Researchers will enroll 477 adults with this serious liver condition to see if these approaches help more patients survive with better liver function after 90 days. The goal is to find better treatments since current options don't work well for everyone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOLIC HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.